145
Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Embed Size (px)

Citation preview

Page 1: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Management of Pregnancy at Risk Chapter 19 & 20

Mary L. Dunlap MSN, APRNFall 2015

Page 2: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

High-Risk Pregnancy

• Jeopardy to mother, fetus, or both• Condition due to pregnancy or result

of condition present before pregnancy• Higher morbidity and mortality• Risk assessment with first Antepartal

visit and each subsequent visit • Risk factors (see Box 19-1 p.605)

Page 3: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Conditions Complicating Pregnancy

• Perinatal Loss• Bleeding• Hyperemesis gravidarum• Gestational hypertension• HELLP syndrome• Gestational diabetes

Page 4: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Perinatal Loss

• Death of a fetus or newborn no matter when it occurs is devastating to the mother and family

• Nurses need to understand their own personal feelings so they can provide support and compassionate care

• What to say- I understand , I am here to listen, Does your baby have a name

Page 5: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Fetal Demise

• Fetal Demise True Story

Page 6: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015
Page 7: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015
Page 8: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Causes of Bleeding

• Spontaneous abortion

• Ectopic pregnancy

• GTD/Hydatiform mole

• Cervical insufficiency

• Placenta Previa• Abruptio

placenta

Page 9: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Spontaneous Abortion

• Termination of pregnancy before viability prior to 20wks less than 500g

• Presentation-Vaginal bleeding and cramping

• Management-Bed rest, serial hCG’s & H&H, Dilation and curettage may be necessary to remove products of conception, RhoGam if mother RH -

Page 10: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Causes

• Congenital abnormalities• Incompetent cervix• Anomaly of the uterine cavity• Hypothyroidism• Diabetes mellitus • Drug use• Infection

Page 11: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Categories of Abortions

• Complete–all products of conception expelled

• Incomplete–a portion of the products of conception retained in the uterus

• Threatened–bleeding and cramping

Page 12: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Categories of Abortions

• Missed– nonviable embryo retained in uterus for at least 6 weeks

• Habitual–three or more successive abortions

• Inevitable–cannot be stopped• Table 19-1 pg. 607

Page 13: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Spontaneous Abortion

Nursing care• Assess bleeding and signs of shock• Assess pain level• Assess for infection• Provide emotional support

Page 14: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Ectopic Pregnancy

• Fertilized ovum implanted outside the uterine cavity usually due to an obstruction of the fallopian tube

• 95%- 99% occur in the fallopian tube• Possible implantation sites Fig 19-1

pg 531

Page 15: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015
Page 16: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Contributing Factors

• Previous ectopic• STD’s• Endometriosis• Tubal or pelvic

surgery

• Uterine fibroids• IUD• Progesterone

only BC pills (slows ovum transport)

Page 17: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Ectopic Pregnancy

Manifestations• Missed menses • Vaginal bleeding & pelvic pain 6-8

wks after missed menses• Diagnosis: Lab test & Ultrasound

Page 18: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Ectopic Pregnancy

Management• Administer Methotrexate, • Surgical-Salpingectomy• Nursing Care: Monitor for shock,

prepare for surgery & provide emotional support

Page 19: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Gestational Trophoblastic Disease (GTD)

• GTD is a disease characterized by an abnormal placental development resulting in the production of fluid filled grape like clusters and vast proliferation of Trophoblastic tissues

• Diagnosis- trans vaginal U.S. showing vesicular molar pattern (grape clusters) high hCG levels

Page 20: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015
Page 21: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

GTD

• Complete (or classic): mole results from fertilization of egg with lost or inactivated nucleus and is associated with Choriocarcinoma

• Partial mole: result of two sperm fertilizing a normal ovum

• Cause unknown

Page 22: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

GTD

Clinical manifestations• Bleeding grape like tissue• Sever Hyperemesis• Uterine size larger than dates• Extremely high hCG levels • Early development preeclampsia

Page 23: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

GTD

Management• Immediate evacuation of uterine

content by Dilatation & suction curettage

• Tissue evaluate for Choriocarcinoma• Follow up for one year

Page 24: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Nursing Assessment• Assess for expulsion of grapelike vesicles• Sever morning sickness due to the high hCG

levels• Unable to detect heart rate after 10-12 wks.• Early development of preeclampsia

(prior to 24 wks.)

GTD

Page 25: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Cervical Insufficiency

• Premature cervical dilatation due to a weak structurally defective cervix that spontaneously dilates in the absence of contractions in the 2nd trimester

• 18–22 wks. Usual time for development

• Repetitive second trimester losses

Page 26: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Possible causes• Trauma to the cervix• Structure of cervix- less collagen and

more smooth muscle

Cervical Insufficiency

Page 27: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Cervical Insufficiency

Management• Bed rest• Pelvic rest• Avoid heavy lifting• Cervical cerclage placed 2nd trimester

if no infection present fig 19.3 pg.615

Page 28: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Cervical Insufficiency

Nursing Assessment Monitor for:• Preterm labor• Backache• Increase vaginal discharge• Rupture of membranes• Contractions

Page 29: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Placenta Previa

• Occurs when the placenta implants near or over internal cervical os

• Classification based on degree internal cervical os is covered by placenta

Page 30: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Placenta Previa

• Complete Placenta Previa • Partial Placental Previa• Marginal Previa• Low-lying

Page 31: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Previa classifications

Page 32: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Placenta Previa

Symptoms• Painless vaginal bleeding that occurs

during the last two months of pregnancy

Page 33: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Placenta Previa

Therapeutic Management• Based on bleeding, location of Previa

and fetal development• “Wait and see” approach if fetus stable

and no active bleeding may go home on bed rest

• Bleeding present admitted to hospital monitoring bleeding, FHR, and avoid vaginal exams.

Page 34: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Placenta Previa

Nursing Management• Monitor vaginal bleeding• Monitor for fetal distress• Provide emotional support• Education• Nursing care plan 19.1 pg. 618 & 619

Page 35: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Abruptio Placenta

• Premature separation of placenta form the uterine wall after 20 weeks of gestation leading to compromised fetal blood supply.

• Significant cause of 3rd trimester bleeding

Page 36: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Abruptio Placenta

Clinical manifestations: • Knife like pain• Port wine vaginal bleeding• Prolonged contraction• Ridged abdomen• Uterine tenderness• Decrease FHR

Page 37: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Abruptio Placenta

Classification systems grades 1,2,3• Grade 1 (mild) less than 500 mL• Grade 2 (moderate) 1000-1500mL• Grade 3 (severe) greater than 1500

Page 38: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Classifications of Abruptio Placenta

Page 39: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Diagnostic Testing

• CBC• Fibrinogen levels• PT/PTT• Type and Cross match• Kleihauer-Betke test• NST• Biophysical Profile

Page 40: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Abruptio Placenta

Management Goal• Assess, control and restore blood loss• Positive out come for mother and Baby• Prevent coagulation disorder

Box 19.2 pg. 621

Page 41: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Abruptio Placenta

Nursing Management• O2 therapy• Monitor FHR tracing• Monitor fundal height• Bed rest- left lateral position• Monitor V.S. for shock• Monitor for DIC• Emotional support

Page 42: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Hyperemesis

• “Morning sickness” normal nausea and vomiting experienced by 80% of pregnant women .

• Symptoms are mild and usually resolve at the end of the first trimester

• Management Teaching Guidelines 19.1 pg. 627

Page 43: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Hyperemesis Gravidarum

• Excessive vomiting accompanied by dehydration, electrolyte imbalance, ketosis, acetonuria and weight loss

• Continues past the 20th wks.• Experiences N&V for the first time after

9 wks.• These mothers require hospitalization

Page 44: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Hyperemesis Gravidarum

• Possible causes: etiology unknown could be due to high hormone levels, low blood glucose levels, Vit B complex and protein deficiency, metabolic stress, depression, elevated thyroid hormone levels

• Collaborative care: GI consult to r/o GI problems , Psychiatric consult , Dietary consult

Page 45: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Hyperemesis Gravidarum

Diagnostic Test• Liver enzymes • CBC• Urine• BUN • Urine specific gravity• Electrolytes • US

Page 46: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Hyperemesis Gravidarum

Management• NPO for 24-36 hr.• IV therapy• Medications-Reglan, Phenergan,

Zofran, Compazine, B6 (19-2 pg.625)• Comfort• Emotional support• Teaching Guidelines 19.1

Page 47: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Hypertension Classification

Chronic Hypertension

Gestational Hypertension

PreeclampsiaEclampsia

Help Syndrome

Page 48: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Assessing Blood Pressure

• Never place patient in Left Lateral Tilt position will give a false lower B/P

• Setting or semi-Fowler’s position• Make sure patient is comfortable• Use the appropriately sized cuff• Cuff needs to be at the level of the right

atrium (mid-sternum• If ≥149/90 recheck in 15 min.

Page 49: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Hypertension Classification

• Chronic hypertension, appears before the pregnancy or the 20th week and is persistence after 12 wks. PP

• Oral antihypertensive are used (avoid ACEs & ARBs due to teratogenic side effects)

Page 50: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Antihypertensive Therapy

• Prevent CVA and maintain placental perfusion

• Apresoline- can cause rebound tachycardia

• Labetalol – beta blocker due not use with asthmatic patients

• Aldomet• Procardia

Page 51: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Hypertensive Emergency

ACOG Guidelines

Acute onset lasting 15 minutes or longer• SBP ≥ 160 mm Hg

or• DBP ≥ 110 mm Hg• Loss of cerebral vasculature auto

regulation• Treat with Hydralazine & Labetalol

Page 52: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Hypertension Classification

• Gestational hypertension- Onset without proteinuria after 20th week of pregnancy and returns to normal by 12 wks. Postpartum

• Mild- SBP 140-159 DBP 90-109• Severe- SBP ≥ 160 DBP ≥ 110

Page 53: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Risk to Fetus

• Progression to preeclampsia• Mild: outcome comparable to no

hypertension• Severe: significant outcome similar to

patient with severe preeclampsia

Page 54: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Management of Mild Gestational Hypertension

• Educate patient about s/s of preeclampsia and when to call provider

• Patient assess daily for signs of preeclampsia and decrease fetal movement

• B/P evaluated twice at week, one being done by provider along with assessing for proteinuria, liver enzymes and platelets

Page 55: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Management of Severe Gestational Hypertension

• Admit to hospital for stabilization• Lower B/P to < 160/110: IV Hydralazine

or labetalol • Monitor B/P and s/s of preeclampsia• Administer oral antihypertensive to

control B/P• Delivery based on fetal status and

gestational age

Page 56: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Hypertension Classification

• Preeclampsia- Hypertension develops after 20 weeks of gestation in previously normotensive woman and proteinuria

• Proteinuria ≥ 300 mg/24hr urine collection

• Protein/creatinine ratio ≥ 0.3 mg/dl

Page 57: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Preeclampsia

• Pathophysiology not understood feel it is a disease of the placenta due to Trophoblastic tissue

• Multisystem disorder• Signs and symptoms develop only

during pregnancy and disappear after birth

• Classifications- Mild, Sever, Eclampsia

Chart 19.2 pg. 629

Page 58: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Preeclampsia Pathophysiology

Decreased placental perfusion

Placental production of a toxic substance endothelin

Vasospasms

Increased Thromboxane

Fluid shift intravascular to

intracellular

Endothelial cell damage

Intravascular

coagulation

Page 59: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Clinical Manifestations

• Classic Triad hypertension, proteinuria, and edema

• New belief edema does not have to be present

• Proteinuria can also be absent if hypertension present along with signs of multisystem involvement

Page 60: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Clinical Manifestations

Headache

Visual Changes

Epigastric Pain

CNS

Irritability

Page 61: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Assessment

• B/P• Edema• Output• Deep tendon reflexes (DTRs)• Clonus • Laboratory tests

Page 62: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Mild Preeclampsia

• B/P greater than 140/90 after 20weeks• Edema- mild facial or hands• Weight gain• Urine protein - 300mg in 24hrs • 1+ to 2+ protein dip stick• Reflexes- normal

Page 63: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Management

• Conservative treatment- bed rest at home, balanced diet and instructed to call provider if any signs of sever preeclampsia develop

• Weekly assessment by provider• Teaching Guidelines 19.2 pg. 632

Page 64: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Sever Preeclampsia • B/P >160/110• Protein 500 mg/24hrs• Urine protein > 3+ • Oliguria- less than 400mL/24hrs• Hyperreflexic• Pulmonary edema• Blurred Visual • Headaches• Epigastric pain

Page 65: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Management

• Hospital care/Seizure precautions• Magnesium sulfate• Blood pressure• Pulmonary edema • Monitor -V.S., DTR’s, Clonus, edema,

urinary output every hour• Continuous FHR monitoring

Page 66: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Magnesium Therapy

• Administration must be verified by a second nurse

• Insert Foley catheter• Monitor V S, Urinary output, reflexes,

and protein level hourly • Monitor patient for toxicity

Page 67: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Magnesium Toxicity

• Absent DTRs (use brachials for pt. with epidural)

• Respirations < 12/min• Urine output < 30 mL/hr.• ↓LOC• Discontinue Magnesium Sulfate and notify

physician• Administer 1 gram 10% calcium gluconate IVP

over 5 min. for respiratory arrest

Page 68: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Hypertension Classification

• Eclampsia- preeclampsia with seizure state

Page 69: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Eclampsia

Symptoms of Sever preeclampsia plus • Marked proteinuria • Seizures/Coma• Hyper reflexive• Possible HELLP syndrome

Page 70: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Eclampsia• Stabilize• Continuous FHR• Seizure precautions• Initiate Magsulfate therapy• Evaluate lab results for HELLP

syndrome• Prepare for delivery

Page 71: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

HELLP Syndrome

Hepatic Dysfunction characterized by•Hemolysis of red blood cells(H)•Elevated liver enzymes (EL)•Low platelets (LP)

Page 72: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

HELLP Syndrome

Increase risk for:• Placental abruption• Acute renal failure• Subcapsular hepatic hematoma• Hepatic rupture• Fetal and maternal death • DIC

Page 73: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

HELLP Syndrome

Management• Transfusion of FF plasma or platelets

to reverse thrombocytopenia (count below 100,000)

• Deliver

Page 74: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Disseminated Intravascular Coagulopathy (DIC)

• Loss of balance between clot-forming thrombin and clot-lysing activity of plasmin

• Box 19.2 pg. 621

Page 75: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

DIC

Symptoms• Widespread external/internal bleeding• Lab results

Decrease fibrinogen/platelets

Prolonged PT/PTT

Positive D-dimer test

Page 76: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Stages Of Clotting Process

Time of Stage Stage Factors Involved Test

I Platelets initiate clotting

Platelets

Takes 3-5 min. II Thromboplastin generated

PTT

Takes 8-16 min. III Prothrombin converted to

Thrombin

PT

Almost instantly IV Fibrinogen converted to fibrin

Fibrin Levels

Page 77: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

DIC

Management • Administer fluids to restore volume

until blood is available• Monitor VS and output• Administer blood and needed blood

components

Page 78: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Diabetes Mellitus

• Diabetes mellitus is the most common endocrine disorder associated with pregnancy

• Before discovery of insulin in 1922, it was uncommon for a woman with diabetes to give birth to a healthy baby

• Pregnancy complicated by diabetes is considered high risk

Page 79: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Diabetes Mellitus

• Metabolic disease characterized by hyperglycemia due to defects in insulin secretion, insulin action, or both.

• Type 1• Type 2• Gestational diabetes mellitus (GDM)

Page 80: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Pregestational Diabetes Mellitus

Goal• Preconception counseling and early

pregnancy glycemic control during organogenesis to reduce the risks of birth defects

• Fetal Basis of Adult Disease Theory

Page 81: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Pregestational Diabetes Mellitus

• Maternal & Fetal risksTable 20-2 pg. 651

Page 82: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Pregestational Diabetes Mellitusand Pregnancy

Plan of care•Diet and exercise• Insulin therapy•Monitoring blood glucose levels•Fetal surveillance•Determination of birth date and mode of birth

Page 83: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Diabetes Mellitus- Gestational (GDM)

• Impairment in CHO metabolism during pregnancy due to placental hormones

• Placental hormones cause insulin resistance

• Beta Cells are unable to produce the required amount of insulin

• Develops during the second trimester

Page 84: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Insulin Needs during Pregnancy

• First trimester: reduced • Second trimester: starts to increases • Third trimester: peaks to provide more

nutrients for the fetus• Delivery: Maternal insulin needs drop

to prepregnancy • Breastfeeding mother: lower insulin

needs

Page 85: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Gestational Screening• ACOG prenatal risk assessment• Screening

When Diagnosis Test Cutoff for Diagnosis

First Prenatal visit

High RiskPatient

FastingHbA1C

Random

60-90 mg/dL<7%

200 mg/dL

24-28 weeks GDM Fasting1hr GTT

3hr GTT

92mg/dL140mg/dL

1hr <180mg/dL2hr <153mg/dL3hr < 140mg/dL

Page 86: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

GDM

• Incidence GDM 2-15%• GDM-A1 able to maintain glycemic

control with diet/exercise• GDM-A2 require medication to

maintain glycemic control

Page 87: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

GDM

• Management• Diet• Exercise• Monitor blood glucose levels• Pharmacologic therapy• Maternal & fetal Surveillance

Page 88: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

GDM

Nursing Management• Educate patient about blood glucose

monitoring, optimal glucose control and fetal well being assessments

• Dietary changes• Exercise• Medications• Teaching Guidelines 20.1 pg. 659

Page 89: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015
Page 90: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Pregnancy at Risk

• Blood incompatibility• Polyhydramnios & Oligohydramnios• Multiple gestation• Premature rupture of membranes• Preterm labor

Page 91: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Blood Incompatibility

Blood type incompatibility• ABO incompatibility: type O mothers

& fetuses with type A or B blood (less severe than Rh incompatibility)

Page 92: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Blood Incompatibility

Rh incompatibility• Exposure of Rh-negative mother to Rh-

positive fetal blood causes sensitization and antibody production

• Risk increases with each subsequent pregnancy and fetus with Rh-positive blood

Page 93: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Blood Incompatibility

• Nursing assessment: maternal blood type and Rh status

• Antibody screen (indirect Coombs)• Nursing management: RhoGAM at 28

weeks

Page 94: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Hydramnios

• Also known as polyhydramnios, too much fluid ( greater than 2000ml)

• Occurs 32-36 weeks• Causes: maternal diabetes, Neural

tube defect, multiple gestation

Page 95: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Hydramnios

Medical Management• Monitor fluid levels• Remove excess amniotic fluid• Administer Indomethacin- decreases

fetal urinary output

Page 96: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Hydramnios

Nursing Management• Monitor for abdominal pain, dyspnea,

uterine contractions and edema of the lower extremities

• Due to the over extension of the uterus educate the patient about the signs and symptoms of preterm labor

Page 97: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Oligohydramnios

• Decrease in amniotic fluid ( less than 500cc) between 32-36 weeks

• Fetus at risk for perinatal morbidity & mortality

• Risk Factors

Page 98: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Oligohydramnios

Nursing Management• Monitor fetal well being• Educate mother about positions that will

encourage the best blood flow to the fetus

• Assist with amnio infusion

Page 99: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Multiple Gestation

• More than one fetus being born to a pregnant women

• The number of multiple gestations have increased due to the use of fertility drugs

• These women are at higher risk for complications

Page 100: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Multiple Gestation

• Monozygotic( Identical)- single fertilized ovum that splits. There is one placenta and chorion and two bags of amniotic fluid

• Dizygotic (Fraternal)- two eggs /sperm

There are two placentas, chorions and bags of amniotic fluid

Page 101: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Multiple Gestation

Page 102: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Multiple Gestation

Medical Management• Serial ultrasounds to assess fetal

growth and development• NST’s and Biophysical profiles to

assess fetal well being• Close monitoring during labor• Operative delivery (common)

Page 103: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Multiple Gestation

Nursing Management• Monitor lab results for anemia• Educate the patient about the need for

adequate nutrition, rest periods, signs and symptoms of preterm labor

Page 104: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Multiple Gestation

Nursing management:• Labor management with perinatal

team on standby• Postpartum assessment for possible

hemorrhage

Page 105: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Premature Rupture of Membranes

• PROM rupture of membranes prior to the onset of labor and is beyond 37 weeks gestation

• PPROM is the preterm premature rupture of membranes prior to the onset of labor prior to the 37th week gestation

Page 106: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Premature Rupture of Membranes

Assessment• Determine if ruptured- Positive Nitrazine

and fern pattern• Transvaginal ultrasound• Vaginal & Cervical culture • Review Box 19.3 pg. 642

Key assessment with PROM

Page 107: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Premature Rupture of Membranes

Management • PROM deliver patient• PPROM if no signs of labor in 48hrs may

discharged to home. • Goal prevent infection, monitor for signs

of labor and promote fetal lung maturity• Review teaching guidelines 19.3 pg 644

Page 108: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Premature Rupture of Membranes

Nursing Management• Focus on preventing infection and

identifying contractions• Monitor V.S.• Monitor fetal heart rate for tachycardia

or variable decelerations• Provide emotional support

Page 109: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Preterm Labor

• Regular uterine contractions with cervical change between 20 to 37 weeks gestation.

• Most common complication• Cause is not always known• Usually due to infection or over

distended uterus

Page 110: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Preterm Labor

Signs of labor• Lighting- fetus dropped into pelvic

cavity• Bloody show• Rupture of membranes

Page 111: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Preterm Labor

Management Goal• Inhibit or reduce contraction strength

and frequency• Optimize fetal status by prolonging

pregnancy• ACOG 2009 recommendations

Page 112: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Preterm Labor

• Fetal Fibronectin • Monitor contraction pattern• Tocolytic therapy Drug guide 21.1 pg. 720

• IV fluids• Betamethasone• Amniocentesis

Page 113: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Preterm Labor

Nursing Management • Educate patient about preterm labor• Preterm labor prevention • Importance of fetal lung maturity• Review Teaching guidelines 21.1 pg.

724

Page 114: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015
Page 115: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Cardiovascular Disorders

• Preconception counseling crucial• Woman with cardiac disease must be

assessed and diagnosed as soon as possible

• Degree of disability important in treatment and prognosis

• Heart Conditions Table 20.3 pg.661 & 662

Page 116: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Cardiovascular Disorders

Heart transplantation• Increasing numbers of heart

recipients are successfully completing pregnancies

• Vaginal birth is desired, but transplant recipients have an increased rate of cesarean births

Page 117: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Cardiovascular Disorders

• Functional classification based on past & present disability & physical signs

• Class I &II can go through a pregnancy without major complications

• Class III bedrest during pregnancy• Class IV should avoid pregnancy• Box 20.1 pg. 663 Mortality risk

Page 118: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Cardiovascular Disorders

• Decompensating is the hearts inability to maintain adequate circulation→ impaired tissue perfusion in the mother & fetus

• Most vulnerable from 28-32 weeks and 48hrs postpartum

• S&S

Page 119: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Care Management

Minimizing heart stress

Weekly Evaluations

Lab and diagnostic

Education signs & symptoms decompensation

Bed rest

Treated Infections promptly

Proper Nutrition

Counseling

Medications

Page 120: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Infections in Pregnancy

Sexually transmitted infections • Chlamydia• Human papillomavirus• Gonorrhea• Herpes simplex virus type 2• Syphilis• Human immunodeficiency virus (HIV)

Review Table 20.4 pg. 677

Page 121: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Infections in Pregnancy

TORCH infection• Capable of crossing placenta and

adversely affecting developing fetus• Produce influenza-like symptoms in

mother• Exposure during first 12 wks. can

cause fetal anomalies

Page 122: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015
Page 123: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

TORCH Infections

• Toxoplasmosis• Other infections• Rubella virus• Cytomegalovirus• Herpes simplex viruses

Page 124: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Toxoplasmosis

• Transferred by hand to mouth after having contact with cat feces or undercooked meat.

• Prevention is the key• Teaching Guidelines 20.5 pg. 683

Page 125: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Hepatitis B Virus

• CDC recommends all pregnant women be tested for hepatitis B surface antigen regardless of previous HBV vaccine or screening

• Infants born from positive mothers need to receive single-antigen HBV vaccine & hepatitis B immunoglobulin within 12 hrs. of birth

Page 126: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Hepatitis B Virus

Nursing assessment• History focused on behavior that puts

her at risk.• Prenatal testing• Can breast feed• No need for surgical delivery• Teaching Guidelines 20.4 pg.680

Page 127: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Group Beta Strep(GBS)

• Causes neonatal sepsis • CDC guideline- vaginal and rectal

culture 35-37 weeks gestation• Mother given antibiotics in labor if

positive, positive with previous pregnancy, ROM greater than 18 hrs, Hx of preterm delivery

Page 128: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Women Who Are HIV Positive

• HIV is a retrovirus that is transmitted by blood and body fluids

• It is a threat to the mother, fetus, and newborn

• To date 20 million women are HIV positive• 2.5 million children and most acquired HIV

via mother to child transmission

Page 129: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Women Who Are HIV Positive

Nursing management• History and physical• Pretest and posttest counseling• Testing for STI’s• Education • Support

Page 130: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Women Who Are HIV Positive

Therapeutic management• Oral antiretroviral drugs twice daily 14

weeks until birth• IV administration during labor• Oral syrup for newborn in 1st 6 weeks of

life

Page 131: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Women Who Are HIV Positive

Labor, Birth, and Postpartum• Elective cesarean birth • Compliance with antiretroviral therapy• Family planning methods

Page 132: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Rubella

• Rubella, German measles, spread by droplet or direct content with contaminated object.

• Risk of transmission via the placenta is greater with early exposure

• Pt. screened at 1st prenatal visit• Avoid exposure to any with Rubella

Page 133: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Cytomegalovirus

• Serious fetal injury occurs when mother develops infection in 1st trimester or early 2nd trimester

• Transmission sexual contact, blood transfusions, kissing, and contact with children in daycare centers.

• No therapy to prevent or treat CMV infection

• Stress good hygiene

Page 134: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Herpes Simplex Virus(HSV)

• HSV-1 and HSV-2 cause oral lesions (fever blisters) and genital lesions

• Transmission occurs by direct contact of the skin or mucous membranes with an active lesion.

• CDC recommends vaginal birth if no lesions are present. If active lesions present pt. should have cesarean birth

Page 135: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Vulnerable Populations

• Adolescents• Pregnant woman over age 35• Women who abuse substances

Page 136: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Pregnant Adolescent

• Adolescence 11-19 yr. old • Vacillate between being children and young

adults• Developmental Tasks• Box 20.3 Factors contributing to pregnancy

Page 137: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Pregnant Adolescent

Nursing assessment• Vision of self in future • Role models • Emotional support• Level of education• Financial/community resource• Anger/conflict resolution skills • Knowledge of health and nutrition for

self and child

Page 138: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Pregnant Adolescent

Nursing management• Support• Future planning (return to school; career

or job counseling); options for pregnancy

• Frequent evaluation of physical and emotional well-being

• Stress management; self-care• Teaching Topics Box 20-6 pg. 691

Page 139: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Woman Over Age 35

Nursing assessment• Preconception counseling; • Laboratory and diagnostic testing for

baseline; amniocentesis; quadruple blood test screen

Page 140: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Woman Over Age 35

Nursing management• Promotion of healthy pregnancy• Education • Regular prenatal care• Dietary teaching• Fetal surveillance

Page 141: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Pregnancy and Substance Abuse

• Women with substance abuse commonly abuse several substances

• Social attitudes prohibit some women from seeking help and admitting they have a problem.

• They will seek prenatal care late in the pregnancy

Page 142: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Pregnancy and Substance Abuse

Impact on pregnancy • Preterm labor• Abortion• Low birth wt. infant• CNS and fetal anomalies• Long term developmental issues• Effect of common substances Table 20-6 pg. 694

Page 143: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Pregnancy and Substance Abuse

Nursing assessment • History and physical • Screening questions Box 20-5 pg. 698• Urine toxicology

Page 144: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Pregnancy and Substance Abuse

Nursing management • Refer for intervention and counseling• Nonjudgmental approach • State protection agency notified of positive

newborn drug screen• Education

Page 145: Management of Pregnancy at Risk Chapter 19 & 20 Mary L. Dunlap MSN, APRN Fall 2015

Alcohol Abuse

• Alcohol is a teratogen and is toxic to human development

• Fetal alcohol spectrum disorder (FSDA)• Cognitive and behavioral problems

associated with FASD Box 20.4 pg. 695• Facial characteristics Figure 20.8 pg 695